Avapro 300 tablet

Avapro (Bristol-Myers Squibb Company), manufactured drug form of Irbesartan, 300mg/tablet irbesartan tablet, NDC 0087-2773

Available in:

NDC Product ID:

  • 0087-2773

Manufacturer:

Manufactured drug form

Manufactured form of:

Generic drug:

  • No

Label date:

  • Jul 1, 2011

Label link:

Label sections:

Section name Section URI Prominent warning Highlight text Section LOINC code
  • Use In Pregnancy
  • Yes
  • When used in pregnancy during the second and third trimesters, drugs that act directly on the renin-angiotensin system can cause injury and even death to the developing fetus. When pregnancy is detected, AVAPRO should be discontinued as soon as possible. See WARNINGS: Fetal/Neonatal Morbidity and Mortality .
  • 34066-1
  • Description
  • No
  • 34089-3
  • Clinical Pharmacology
  • No
  • 34090-1
  • Indications And Usage
  • No
  • 34067-9
  • Contraindications
  • No
  • 34070-3
  • Warnings
  • No
  • 34071-1
  • Precautions
  • No
  • 42232-9
  • Adverse Reactions
  • No
  • 34084-4
  • Overdosage
  • No
  • 34088-5
  • Dosage And Administration
  • No
  • 34068-7
View entire collection »

Discontinued:

  • No

Marketing start date:

  • Sep 30, 1997

Patents:

Patent expiry date:

  • Dec 7, 2015

FDA application number:

  • NDA020757

Color:

Shape:

Size:

  • 17 mm (0.67 in )

Scoring:

  • 1

Imprint:

  • 2773

Therapeutic equivalents:

View entire collection »
top ↑

Consumer product

Brand:

top ↑

You can help improve this topic by adding more facts here

Edit this topic
Edit and Show details

Add or delete facts, download data in JSON or RDF formats, and explore topic metadata.

Freebase Logo
What is Freebase?

Freebase is a huge collection of facts, built by people like you. Freebase connects facts in ways other sites can't, giving you new ways to explore millions of subjects.
You can help improve it!